Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Ayman Saad; Alankrita Taneja; Antonio Di Stasi; Rehan Sarmad; Rivvi Kukkamalla; Luciano Costa; Donna Salzman; Racquel Innis-Shelton; Joseph H. Chewning; Ruby F. Meredith; Vera Hauptfeld; Samantha Langford; Kirby Ann Plessala; Ravi Bhatia; Lawrence S. Lamb; Shin Mineishi

doi:10.1038/s41409-018-0185-6

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Ayman Saad
, Alankrita Taneja
, Antonio Di Stasi
, Rehan Sarmad
, Rivvi Kukkamalla
, Luciano Costa
, Donna Salzman
, Racquel Innis-Shelton
, Joseph H. Chewning
, Ruby F. Meredith
, Vera Hauptfeld
, Samantha Langford
, Kirby Ann Plessala
, Ravi Bhatia
, Lawrence S. Lamb
, Shin Mineishi

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1345-1348
Number of pages	4
Journal	Bone Marrow Transplantation
Volume	53
Issue number	10
DOIs	https://doi.org/10.1038/s41409-018-0185-6
State	Published - Oct 1 2018

All Science Journal Classification (ASJC) codes

Hematology
Transplantation

Access to Document

10.1038/s41409-018-0185-6

Cite this

Saad, A., Taneja, A., Di Stasi, A., Sarmad, R., Kukkamalla, R., Costa, L., Salzman, D., Innis-Shelton, R., Chewning, J. H., Meredith, R. F., Hauptfeld, V., Langford, S., Plessala, K. A., Bhatia, R., Lamb, L. S., & Mineishi, S. (2018). Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant. Bone Marrow Transplantation, 53(10), 1345-1348. https://doi.org/10.1038/s41409-018-0185-6

@article{23108f0508c34c1b8df69276612e2bd2,

title = "Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant",

author = "Ayman Saad and Alankrita Taneja and \{Di Stasi\}, Antonio and Rehan Sarmad and Rivvi Kukkamalla and Luciano Costa and Donna Salzman and Racquel Innis-Shelton and Chewning, \{Joseph H.\} and Meredith, \{Ruby F.\} and Vera Hauptfeld and Samantha Langford and Plessala, \{Kirby Ann\} and Ravi Bhatia and Lamb, \{Lawrence S.\} and Shin Mineishi",

note = "Funding Information: Conflict of Interest Ayman Saad: royalty for licensing of intellectual property (Incysus Biomedical), grant support (American Porphyria foundation), consultant fees (Actinium Pharma Inc), Research support (Astellas and Fate Therapeutics), and Honoraria (Alexion and Spectrum Pharmaceutical). Lawrence lamb: Chair, Incysus Scientific Advisory Board. The authors declare that they have no conflict of interest.",

year = "2018",

month = oct,

day = "1",

doi = "10.1038/s41409-018-0185-6",

language = "English (US)",

volume = "53",

pages = "1345--1348",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "10",

}

Saad, A, Taneja, A, Di Stasi, A, Sarmad, R, Kukkamalla, R, Costa, L, Salzman, D, Innis-Shelton, R, Chewning, JH, Meredith, RF, Hauptfeld, V, Langford, S, Plessala, KA, Bhatia, R, Lamb, LS & Mineishi, S 2018, 'Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant', Bone Marrow Transplantation, vol. 53, no. 10, pp. 1345-1348. https://doi.org/10.1038/s41409-018-0185-6

TY - JOUR

T1 - Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

AU - Saad, Ayman

AU - Taneja, Alankrita

AU - Di Stasi, Antonio

AU - Sarmad, Rehan

AU - Kukkamalla, Rivvi

AU - Costa, Luciano

AU - Salzman, Donna

AU - Innis-Shelton, Racquel

AU - Chewning, Joseph H.

AU - Meredith, Ruby F.

AU - Hauptfeld, Vera

AU - Langford, Samantha

AU - Plessala, Kirby Ann

AU - Bhatia, Ravi

AU - Lamb, Lawrence S.

AU - Mineishi, Shin

N1 - Funding Information: Conflict of Interest Ayman Saad: royalty for licensing of intellectual property (Incysus Biomedical), grant support (American Porphyria foundation), consultant fees (Actinium Pharma Inc), Research support (Astellas and Fate Therapeutics), and Honoraria (Alexion and Spectrum Pharmaceutical). Lawrence lamb: Chair, Incysus Scientific Advisory Board. The authors declare that they have no conflict of interest.

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://www.scopus.com/pages/publications/85046449305

UR - https://www.scopus.com/pages/publications/85046449305#tab=citedBy

U2 - 10.1038/s41409-018-0185-6

DO - 10.1038/s41409-018-0185-6

M3 - Letter

C2 - 29728698

AN - SCOPUS:85046449305

SN - 0268-3369

VL - 53

SP - 1345

EP - 1348

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 10

ER -

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this